Quantitative Learning of Cellular Features From Single-cell Transcriptomics Data Facilitates Effective Drug Repurposing
Zhong, J.; Yang, J.; Song, Y.; Zhang, Z.; Wang, C.; Tong, R.; Li, C.; Yu, N.; Zou, L.; Liu, S.; Pu, J.; Lin, W.
Show abstract
In this study, we have devised a computational framework SuperFeat that allows for the training of a machine learning model and evaluate the canonical cellular states/features in pathological tissues that underlie the progression of disease. This framework also enables the identification of potential drugs that target the presumed detrimental cellular features. This framework was constructed on the basis of an artificial neural network with the gene expression profiles serving as input nodes. The training data comprised single-cell RNA-seq datasets that encompassed the specific cell lineage during the developmental progression of cell features. A few models of the canonical cancer-involved cellular states/features were tested by such framework. Finally, we have illustrated the drug repurposing pipeline, utilizing the training parameters derived from the adverse cellular states/features, which has yielded successful validation results both in vitro and in vivo. SuperFeat is accessible at https://github.com/weilin-genomics/rSuperFeat.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- DNFE: Directed-network flow entropy for detecting the tipping points during biological processes 96%
- Inferring latent temporal progression and regulatory networks from cross-sectional transcriptomic data of cancer samples 96%
- Cell-type annotation with accurate unseen cell-type identification using multiple references 96%
Similar papers in this journal
- A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer 96%
- Mapping of single-cell landscape of acral melanoma and analysis of molecular regulatory network of tumor microenvironment 95%
- Multi-gradient Permutation Survival Analysis Identifies Mitosis and Immune Signatures Steadily Associated with Cancer Patient Prognosis 95%
Similar papers in this journal
- scPharm: identifying pharmacological subpopulations of single cells for precision medicine in cancers 96%
- ImmuCellAI: a unique method for comprehensive T-cell subsets abundance prediction and its application in cancer immunotherapy 96%
- Transfer Learning and Permutation-Invariance improving Predicting Genome-wide, Cell-Specific and Directional Interventions Effects of Complex Systems 95%